Login/Sign Up
Ebunat 0.5 mg Injection 2 ml is used to treat Breast Cancer and Liposarcoma (cancer that develops in your fatty tissue). It contains Eribulin, which works by stopping the cancer cells from separating into two new cells. So, it blocks the growth of the cancer. It is expected to cause fetal harm when administered to a pregnant woman, so it should not be used in pregnant women. While on therapy with this medicine, both women and men should use birth control to avoid pregnancy. Discontinue nursing while on treatment, considering the importance of the drug to the mother.
₹16072*
MRP ₹19600
18% off
₹16660*
MRP ₹19600
15% CB
₹2940 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
About Ebunat 0.5 mg Injection 2 ml
Ebunat 0.5 mg Injection 2 ml belongs to a group of medicines known as 'anti-cancer' used to treat various cancers, including breast and liposarcoma. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. Breast cancer is cancer that forms in the cells of the breasts. A liposarcoma is a rare cancer that develops in your fatty tissue.
Ebunat 0.5 mg Injection 2 ml contains Eribulin, which works by stopping the cancer cells from separating into two new cells. So, it blocks the growth of the cancer.
Ebunat 0.5 mg Injection 2 ml should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents. The most common adverse reactions that occur while on therapy are neutropenia (lower-than-normal levels of neutrophils), anaemia (lack of blood), asthenia (weakness), fatigue(tiredness), alopecia (hair loss), peripheral neuropathy (Weakness, numbness, and pain from nerve damage), nausea, and constipation. Most of these side effects of Ebunat 0.5 mg Injection 2 ml do not require medical attention and gradually resolve over time. However, if the side effects persist, contact your doctor.
To treat your condition effectually, continue taking Ebunat 0.5 mg Injection 2 ml for as long as your doctor has prescribed. Do not stop using the Ebunat 0.5 mg Injection 2 ml midway. It is expected to cause fetal harm when administered to a pregnant woman, so it should not be used in pregnant women. Both women and men using this Ebunat 0.5 mg Injection 2 ml should use birth control to avoid pregnancy. Discontinue nursing while on therapy, considering the importance of the drug to the mother. Caution should be exercised while using Ebunat 0.5 mg Injection 2 ml in patients with hepatic, renal, heart dysfunction and or Neutropenia (Lower-than-normal levels of neutrophils), so inform your doctor about all your medical conditions and medications you are currently taking.
Uses of Ebunat 0.5 mg Injection 2 ml
Medicinal Benefits
Ebunat 0.5 mg Injection 2 ml contains Eribulin, which belongs to a group of medicines known as 'anti-cancer' used to treat various types of cancers, including breast and liposarcoma. It works by stopping the cancer cells from separating into two new cells. So, it blocks the growth of the cancer.
Side Effects of Ebunat 0.5 mg Injection 2 ml
Directions for Use
Storage
Drug Warnings
Before taking the Ebunat 0.5 mg Injection 2 ml, let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. Before taking Ebunat 0.5 mg Injection 2 ml, inform your doctor about your medical history and other medications you are currently taking in order to rule out any potential negative effects. Ebunat 0.5 mg Injection 2 ml may cause permanent fertility problems in men if they take it. Please discuss this with their doctor before starting treatment. Women of childbearing age should use effective contraception during and up to 3 months after treatment with Ebunat 0.5 mg Injection 2 ml. Avoid the consumption of alcoholic beverages and grapefruit juices.
Therapeutic Class
Drug-Drug Interactions
Drug-Food Interactions
Diet & Lifestyle Advise
Habit Forming
How Ebunat 0.5 mg Injection 2 ml Works
What if I have taken an overdose of Ebunat 0.5 mg Injection 2 ml
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Ebunat 0.5 mg Injection 2 ml.
Pregnancy
Unsafe
Ebunat 0.5 mg Injection 2 ml should not be used during pregnancy because it can harm your fetus (newborn baby).
Breast Feeding
Unsafe
Do not breastfeed during this treatment because the medicine may pass into your milk. Doctors normally advise against breastfeeding throughout this treatment and for a certain period of time after the final medication is taken.
Driving
Caution
Ebunat 0.5 mg Injection 2 ml may cause side effects such as tiredness and dizziness. Do not drive or use machines if you feel tired or dizzy.
Liver
Caution
A lower starting dose is recommended for patients with mild (Child-Pugh A) and moderate (ChildPugh B) liver impairment. There is no information available on patients with severe liver impairment.
Kidney
Caution
A lower starting dose is recommended for patients with moderate (CrCl 30-50 mL/min) kidney impairment. There is no information available on patients with severe kidney impairment.
Children
Unsafe
Do not use this medicine for children between 0 to 18 years old.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes